A peptide construct mediates focal adhesion pathway through activation of integrin receptor.

The integrin family receptors stimulate the cellular proliferation and migration through the focal adhesion pathway by the activation of PTK2, VASP and TSP1 proteins. The purpose of this study was to investigate the integrin-ligated motifs through the activation of focal adhesion pathway. A chimeric peptide was predicted from the integrin-mediated ligands by bioinformatics tools. The VSMCs were treated with the chimeric peptide and simvastatin. The PTK2, VASP and TSP1 protein and gene expression levels were measured by RT-qPCR and Western Blotting techniques, respectively. AutoDock Tools were used for the docking technique. The PTK2, VASP and TSP1 protein expression levels increased significantly in the VSMCs treated with chimeric peptide in conversely with the effects of simvastatin. The docking results suggested two motifs in the chimeric peptide. In conclusion, the chimeric peptide activated the focal adhesion pathway. The motifs 1 and 2 may be directly involved in the transduction of signal by integrin family receptors.

[1]  Wei Wu,et al.  Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway , 2018, Cancer Cell International.

[2]  D. Tulis Novel protein kinase targets in vascular smooth muscle therapeutics , 2017, Current opinion in pharmacology.

[3]  K. Stokes,et al.  Integrin signaling in atherosclerosis , 2017, Cellular and Molecular Life Sciences.

[4]  D. Tulis AMP-Activated Protein Kinase Inhibits Arterial Smooth Muscle Cell Proliferation in Vasodilator-Stimulated Phosphoprotein-Dependent Manner , 2016 .

[5]  Li Wang,et al.  FAK Promotes Osteoblast Progenitor Cell Proliferation and Differentiation by Enhancing Wnt Signaling , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  D. Galileo,et al.  Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation , 2016, Cellular Oncology.

[7]  V. Gahtan,et al.  Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. , 2015, Biochemical and biophysical research communications.

[8]  Mark R Morgan,et al.  Emerging properties of adhesion complexes: what are they and what do they do? , 2015, Trends in cell biology.

[9]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[10]  A. Orekhov,et al.  Vascular smooth muscle cell in atherosclerosis , 2015, Acta physiologica.

[11]  G. Taraboletti,et al.  Current understanding of the thrombospondin-1 interactome. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[12]  V. Gahtan,et al.  Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. , 2014, Surgery.

[13]  T. Ross,et al.  Integrins in mechanotransduction. , 2013, Current opinion in cell biology.

[14]  Jordan D. Miller Cardiovascular calcification: Orbicular origins. , 2013, Nature materials.

[15]  J. C. Fox,et al.  AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. , 2013, American journal of physiology. Heart and circulatory physiology.

[16]  B. Gückel,et al.  Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin. , 2011, International journal of oncology.

[17]  Michael W. Davidson,et al.  Nanoscale architecture of integrin-based cell adhesions , 2010, Nature.

[18]  V. Gahtan,et al.  Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. , 2009, American journal of surgery.

[19]  Arif Yurdagul,et al.  Molecular Mechanisms of Collagen Isotype-Specific Modulation of Smooth Muscle Cell Phenotype , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Parsons,et al.  FRNK Expression Promotes Smooth Muscle Cell Maturation During Vascular Development and After Vascular Injury , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  S. Yagihashi,et al.  Simvastatin inactivates β1‐integrin and extracellular signal‐related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells , 2007 .

[22]  P. Bornstein,et al.  Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells* , 2007, Journal of Biological Chemistry.

[23]  C. Gladson,et al.  New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.

[24]  J. Bonnet,et al.  Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation. , 2002, Cardiovascular research.

[25]  E. Fleck,et al.  Integrins αvβ3 and αvβ5 mediate VSMC migration and are elevated during neointima formation in the rat aorta , 2001, Basic Research in Cardiology.

[26]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.